Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS study

被引：0
|
作者：
Antoinette MaassenVanDenBrink
Gisela M. Terwindt
Joshua M. Cohen
Steve Barash
Verena Ramirez Campos
Maja Galic
Xiaoping Ning
Mikko Kärppä
机构：
[1] Erasmus University Medical Center Rotterdam,Division of Pharmacology and Vascular Medicine, Department of Internal Medicine
[2] Leiden University Medical Center,Department of Neurology
[3] Teva Pharmaceutical Products R&D,Research Unit of Clinical Neuroscience
[4] Inc.,undefined
[5] Teva Pharmaceuticals Europe B.V.,undefined
[6] University of Oulu and Medical Research Center,undefined
[7] Oulu University Hospital,undefined
来源：
The Journal of Headache and Pain | 2021年 / 22卷
关键词：
Fremanezumab; Calcitonin gene-related peptide; Age; Sex; Migraine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 47 条
  • [41] Impact of galcanezumab on total pain burden: findings from phase 3 randomized, double-blind, placebo-controlled studies in patients with episodic or chronic migraine (EVOLVE-1, EVOLVE-2, and REGAIN trials)
    Jessica Ailani
    J. Scott Andrews
    Mallikarjuna Rettiganti
    Robert A. Nicholson
    The Journal of Headache and Pain, 2020, 21
  • [42] Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double-Blind, Placebo-Controlled REGAIN, and Pooled EVOLVE-1 and EVOLVE-2 Studies
    Smitherman, Todd A.
    Tietjen, Gretchen E.
    Schuh, Kory
    Skljarevski, Vladimir
    Lipsius, Sarah
    D'Souza, Deborah N.
    Pearlman, Eric M.
    HEADACHE, 2020, 60 (10): : 2202 - 2219
  • [43] Evaluation of Cardiovascular Outcomes in Adult Patients With Episodic or Chronic Migraine Treated With Galcanezumab: Data From Three Phase 3, Randomized, Double-Blind, Placebo-Controlled EVOLVE-1, EVOLVE-2, and REGAIN Studies
    Oakes, Tina M.
    Kovacs, Richard
    Rosen, Noah
    Doty, Erin
    Kemmer, Phebe
    Aurora, Sheena K.
    Camporeale, Angelo
    HEADACHE, 2020, 60 (01): : 110 - 123
  • [44] Efficacy and safety of prucalopride in patients with chronic idiopathic constipation stratified by age, body mass index, and renal function: a post hoc analysis of phase III and IV, randomized, placebo-controlled clinical studies
    Lembo, Anthony
    Staller, Kyle
    Boules, Mena
    Feuerstadt, Paul
    Spalding, William
    Gabriel, Andre
    Youssef, Ashraf
    Xie, Yunlong
    Terreri, Brian
    Cash, Brooks D.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2024, 17
  • [45] Preventive effects of galcanezumab in adult patients with episodic or chronic migraine are persistent: data from the phase 3, randomized, double-blind, placebo-controlled EVOLVE-1, EVOLVE-2, and REGAIN studies
    Foerderreuther, Stefanie
    Zhang, Qi
    Stauffer, Virginia L.
    Aurora, Sheena K.
    Lainez, Miguel J. A.
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [46] Preventive effects of galcanezumab in adult patients with episodic or chronic migraine are persistent: data from the phase 3, randomized, double-blind, placebo-controlled EVOLVE-1, EVOLVE-2, and REGAIN studies
    Stefanie Förderreuther
    Qi Zhang
    Virginia L. Stauffer
    Sheena K. Aurora
    Miguel J. A. Láinez
    The Journal of Headache and Pain, 2018, 19
  • [47] Results of a multicenter, double-blind, randomized, parallel-group, placebo-controlled, single-dose study comparing the fixed combination of acetaminophen, acetylsalicylic acid, and caffeine with ibuprofen for acute treatment of patients with severe migraine
    Goldstein, Jerome
    Hagen, Martina
    Gold, Morris
    CEPHALALGIA, 2014, 34 (13) : 1070 - 1078
12345